MHRA Approves Moderna’s mRNA COVID-19 Vaccine

Medicines and Healthcare products Regulatory Agency (MHRA), the regulator of all medicines and medical devices in the UK has approved Moderna’s COVID-19 vaccine after meeting the required safety, quality and effectiveness standards for use in the UK (1).  

This is the third COVID-19 vaccine to be approved in the UK after Pfizer/BioNTech’s mRNA vaccine BNT162b2 and Oxford/AstraZeneca’s ChAdOx1 nCoV-2019.  

Like Pfizer/BioNTech’s BNT162b2, this vaccine as well is a mRNA vaccine and works on the same principle of injecting viral mRNA in to the cells (2).  

***

Sources:  

  1. MHRA 2021. Press release – Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator. Published 8 January 2021. Available on https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator Accessed on 08 January 2021  
  1. Prasad U., 2020. COVID-19 mRNA Vaccine: A Milestone in Science and a Game Changer in Medicine. Scientific European. Posted online on 29 December 2020. Available online on http://scientificeuropean.co.uk/medicine/covid-19-mrna-vaccine-a-milestone-in-science-and-a-game-changer-in-medicine/ Accessed on 08 January 2021.  

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

A New Blood Test for Undetectable Cancers in Early Stages

In a major advancement in cancer screening, new study...

Thapsigargin (TG): A Potential Anti-cancer and Broad-spectrum Anti-viral Agent That May be Effective Against SARS-CoV-2

The plant derived agent, Thapsigargin (TG) has been used in traditional...

The First Ever Image of The Shadow of a Black Hole

Scientists have successfully taken first ever picture of the...

Sea level along USA coastline to rise about 25-30 cm by 2050

Sea level along USA coastlines will rise about 25...

Polar Bear Inspired, Energy-efficient Building Insulation

Scientists have designed a nature-inspired carbon tube aerogel thermal...

Mobile Telephony Offers Novel Ways to Diagnose, Track and Control Diseases

Studies show how existing smartphone technology, in Combination with...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

2 COMMENTS

Comments are closed.